Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Assessment of antiplateled medicines consumption in Serbia during the period 2003-2005 years

  • At: 2006 FIP Congress in Salvadore (Brazil)
  • Type: Poster
  • By: RADONJIC (Medicines and Medical devices Agency, Belgrade, Yugoslavia)
  • Co-author(s): Radonjic, Vesela (Medicines and Medical devices Agency, Belgrade, Yugoslavia)
    Solarovic, Tomislav (Medicines and Medical devices Agency, Belgrade, Yugoslavia)
  • Abstract:

    Antiplatelet therapy is a necessary life-long treatment for all patients at risk of atherothrombosis. Atherothrombosis is an extensive, progressive, unpredictable and deadly disease affecting the coronary, cerebral and peripheral circulation The aim of our study was the following consumption of Antiplatelet medicines in Serbia during the three

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses